NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today reported that its fourth quarter 2013 revenues climbed 6 percent year over year with high- to mid-single digit growth across all three of its reporting segments.

The firm reported total revenues of $3.47 billion for the three months ended Dec. 31, compared to $3.26 billion for the fourth quarter of 2012. It beat the consensus analyst estimate of $3.31 billion for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."